|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2001-9-25
|
|
pubmed:abstractText |
The objective of this study was to determine the effect of dose and its interaction with known prognostic variables, including pretreatment prostate specific antigen (PSA), Gleason score (GS), and T classification, on patients with nonmetastatic prostate carcinoma treated with three-dimensional conformal radiation therapy (3DCRT) alone using recursive partitioning analysis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2001 American Cancer Society.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
92
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1281-7
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11571744-Adult,
pubmed-meshheading:11571744-Aged,
pubmed-meshheading:11571744-Aged, 80 and over,
pubmed-meshheading:11571744-Algorithms,
pubmed-meshheading:11571744-Decision Trees,
pubmed-meshheading:11571744-Humans,
pubmed-meshheading:11571744-Male,
pubmed-meshheading:11571744-Middle Aged,
pubmed-meshheading:11571744-Prognosis,
pubmed-meshheading:11571744-Prostate-Specific Antigen,
pubmed-meshheading:11571744-Prostatic Neoplasms,
pubmed-meshheading:11571744-Radiotherapy, Conformal,
pubmed-meshheading:11571744-Radiotherapy Dosage,
pubmed-meshheading:11571744-Survival Rate
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Defining the optimal radiation dose with three-dimensional conformal radiation therapy for patients with nonmetastatic prostate carcinoma by using recursive partitioning techniques.
|
|
pubmed:affiliation |
Fox Chase Cancer Center, Department of Radiation Oncology, Philadelphia, Pennsylvania 19111, USA. em_horwitz@fccc.edu
|
|
pubmed:publicationType |
Journal Article
|
